New shot targets leukemia that chemo Can't beat
NCT ID NCT07371533
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental antibody drug called A-319 for people with a type of leukemia (B-ALL) that has come back or not fully cleared after chemotherapy. The drug is given as a shot under the skin and aims to help the immune system attack cancer cells. The main goals are to check if it is safe and how well it works. Only 18 adults aged 18 to 75 will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New transplant recipe aims to tame Graft-Versus-Host disease
- Experimental drug RAD001 tested for tough leukemias and lymphomas
- Engineered immune cells take aim at returning blood cancers
- Selective immune cell removal may tame transplant complications
- New hope for tough blood cancers: LP-118 trial launches
- New safety check for Kids' leukemia drug BESPONSA